Drug Trial Radar · NCT00779714
Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC
Last checked: Nov 20, 2026Latest source record: Oct 24, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
360
Planned (sponsor's estimate)
Start
Oct 2008
Primary completion
Oct 2012
Study completion Apr 2013
Sponsor
- Lead sponsor
- University of WuerzburgAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Hiege-Stiftung gegen Hautkrebs; medac GmbH; DCS Innovative Diagnostik Systeme
- First posted
- Oct 24, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial is aimed to investigate the efficacy of an individualized, sensitivity-directed combination chemotherapy in comparison to the standard regimen DTIC. Two question are aimed to be answered by this study: 1. Is the individual chemosensitivity index (BICSI) a prognostic / predictive biomarker for chemotherapy ? 2. Is an individualized, sensitivity-directed combination chemotherapy superior to the standard regimen DTIC in terms of survival and response ?
Conditions
- Melanoma
Interventions
DTIC (dacarbazine)Drug
1000 mg/m2, d1 every 21 days
paclitaxel + cisplatinDrug
paclitaxel 200 mg/m2 cisplatin 50 mg/m2 d1 every 21 days
treosulfan + cytarabineDrug
treosulfan 2500 mg/m2, d2 cytarabine 100 mg/m2, d1-3 every 21 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-specific overall survivalTime frame: 4 years
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Dept of Dermatology, University of Aachen
Aachen, Germany · Recruiting
Dept of Dermatology, University of Berlin Charite
Berlin, Germany · Recruiting
Dept of Dermatology, University of Bochum
Bochum, Germany · Recruiting
Medizinisches Zentrum Bonn Friedensplatz
Bonn, Germany · Recruiting
Dept of Dermatology, University of Essen
Essen, Germany · Recruiting
Dermatology, Klinikum Frankfurt/Oder
Frankfurt (Oder), Germany · Recruiting
Dept of Dermatology, University of Frankfurt
Frankfurt am Main, Germany · Recruiting
Dept of Dermatology, University of Hannover
Hanover, Germany · Recruiting
Dept of Dermatology, Saarland University
Homburg/Saar, Germany · Recruiting
Dept of Dermatology, University of Jena
Jena, Germany · Recruiting
Dept of Dermatology, University of Schleswig-Holstein Campus Kiel
Kiel, Germany · Recruiting
Dept of Dermatology, University of Schleswig-Holstein Campus Luebeck
Lübeck, Germany · Recruiting
Dermatology, Klinikum Ludwishafen
Ludwigshafen, Germany · Recruiting
Dept of Dermatology, Univeristy of Magdeburg
Magdeburg, Germany · Recruiting
Dept of Dermatology, University of Mainz
Mainz, Germany · Recruiting
Dept of Dermatology, University of Mannheim
Mannheim, Germany · Recruiting
Dept of Dermatology, University of Marburg
Marburg, Germany · Recruiting
Dept of Dermatology, University of Muenchen
München, Germany · Recruiting
Dept of Dermatology, University of Muenster
Münster, Germany · Recruiting
Dept of Medical Oncology, Fachklinik Hornheide
Münster, Germany · Recruiting
Dermatology, Klinikum Dorothea Christiane Erxleben
Quedlinburg, Germany · Recruiting
Dept of Dermatology, University of Tuebingen
Tübingen, Germany · Recruiting
Dept of Dermatology, University of Wuerzburg
Würzburg, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.